The use of an insuflon device for the administration of G-CSF in pediatric cancer patients

被引：6

作者：

de Jong, MEA

Carbière, T

van den Heuvel-Eibrink, MM

机构：

[1] Sophia Childrens Univ Hosp, Dept Hematol Oncol, NL-3015 Rotterdam, Netherlands

[2] Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Dept Pediat Oncol Hematol, Rotterdam, Netherlands

来源：

SUPPORTIVE CARE IN CANCER | 2006年 / 14卷 / 01期

关键词：

granulocyte colony-stimulating factor; insuflon device; pediatric cancer;

D O I：

10.1007/s00520-005-0872-x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In pediatric oncology, granulocyte colony-stimulating factor (G-CSF) is applied with the aim of shortening neutropenic periods after chemotherapy and for mobilization of peripheral blood stem cells for apheresis procedures. G-CSF is administered, subcutaneously or intravenously, on a daily basis. An insuflon device for the administration of G-CSF was used in 29 patients for 93 G-CSF periods. Retrospective evaluation shows that this administration route is feasible, safe and preferred by young children rather than by teenagers with cancer.

引用

页码：98 / 100

页数：3

共 11 条

[1] Optimal use of granulocyte-colony-stimulating factor in patients with cancer who are at risk for chemotherapy-induced neutropenia [J].